Tweet
From Byrne Hobart's The Diff: "Pfizer turned down funding for research, but accepted a preorder, because they didn't want to get slowed down."
This is little more than a convenient narrative.
@ByrneHobart @MazzucatoM
This is little more than a convenient narrative.
@ByrneHobart @MazzucatoM